We conducted a retrosp ective study of6,966 pati ents who had undergone tonsillectomy or adenotonsillectoniy to evaluate the incidence and clinicalfeatures ofpreviously unidentified coagulation disord ers in patients who experienced postop erative hemorrhage (n = 201). We f ound that post-tonsillectomy hemorrha ge seconda ry to unidentified coagulation disorders is extremely rare. However, normal coagulation values and an insignificant history do not rule out coagulation disorders . If diffus e, persistent, and bilateral bleeding is not related to arterial hypertension, dissection technique, or local infection, a rapid and detailed analysis ofcoagulationfactors should be considered.
Introduction
Tonsillectomy, with or without adenoidectomy, remains one of the most commonly performed surgical procedures in otolaryngology. For most patients in the pediatric age group , the operation is the first major challenge to their hemostatic system. A decade ago, approximately 285,000 of these surgical procedures were performed in the United States, I more than 80,000 in Engl and and Wales ,' and approximately 200 ,000 in Germany. ' Unlike the case with other surgical procedures, the surface of the large mucosal wound is not closed following tonsillectomy. Instead, it is left to achieve secondary healing. However, during healing , the wound is exposed to bacteria-and enzyme-containing saliva close to the larger vessels of the neck.
Although outpatient tonsillectomy and adenotonsillec-tomy can be performed safely , a personal or family history of abnormal coagulation, with or without an identified bleeding disorder, certainly warrants overnight observation in an appropriate setting with skilled staff.' Primary «24 hr) post-tonsillectomy hemorrhage is acknowledged to be more dangerous than bleeding that occurs later because larger amounts of blood can be swallowed or aspirated during early bleeding. In fact, deaths during the early phase following tonsillectomy have been reported. ' The American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) suggests that surgeons conduct a coagulation and bleeding work-up on any patient who is suspected of having such an abnormality on the basis of the history and in any patient for whom genetic information is unavailable." However, intra-or postoperative hemorrhage that is the result of a coagulation disorder can occur in patients whose laboratory coagulation values are normal. Our experience with a dramatic postoperative course following tonsillectomy in an adult with normal coagulation values and an insignificant history encouraged us to conduct a retrospective study to evaluate the incidence and clinical feature s of previously undetected coagulation disorders that becam e evident only after the tonsillectomy.
Patients and methods
Between Jan. 1, 1989, and June 30, 2002, 6 ,966 patients underwent tonsillectomy or adenotonsillectomy at our clinic . This group was made up of 3,574 males (51.3 %) and 3,392 females (48.7 %), aged 5 months to 93 years (mean: 22.2 yr; median 18±17.2). Most were between 5 and 29 years of age (figure 1).
Before surgery, a standardized questionnaire was used to elicit detailed personal and family histories regarding bleeding, intake of drug s that affect coagulation or inhibit platelet function, abnormal epistaxis, bruising or bleeding after injuries or previous surgery (including tooth extraction and circumci sion) , and medical conditions that affect hemostasis (e.g., liver disease , uremia, and malabsorp- "we love the Otogram. It meets our needs to improve workflow and provide cost-effective testing on demand. "
Ted Brown, M.D., Spring Hill, FL
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Review test results with patient Easy-to-Read Automated Report For more information or a FREE demonstration, please call 866.316.3606 or visit us on the web at www.tympany.net Of the 2 16 episo des of bleedin g, 168 (77.8 %) occurred within 24 hours of surgery-that is, they were prim ary hem orrhages (figure 2). In 199 of the 20 I patient s, we determ ined that the bleedi ng had not been relat ed to a coagulation disord er. We were able to ide ntify a unilateral bleedi ng vesse l in these patient s, and we determined that the bleed ing was related to either the dissection tec hnique or to arterial hypertension (either tem porary or perma nent). 
Results
Of the 6,966 patient s, routine tonsillectomy was perform ed on 3,076 (44.2%), adenotonsill ectom y on 2, I60 (3 1.0%), immedi ate-abscess ton sillectomy on 1,595 (22.9%), rec urren t tonsillec tomy to remov e remnants of lym phatic tissue on 107 ( 1.5%), and ton sillectomy to resolve obstru ction of the upper airwa ys secondary to infectious mononucleosis in 28 (0.4%).
Post-ton sillectom y hem orrhage occurred in 20 I pati ent s (2.9%); I I of these pati ent s experienced two bleed s and 2 oth ers experienced three bleed s (total bleeds: tion ). Regular intake of aspirin was permitted unt il 7 days before surgery.
In additio n, all patients were screened by several laboratory test s, including mea surem ent of the compl ete blood count (CBC), includin g platelet count; proth rombin time (PT) to eva luate the extrin sic coag ulation pathw ay (factor II, V, VII , and X activity), which were con verted to calcul ate the International Normalized Ratio (INR)?; and activa ted partia l thromboplastin tim e (aPTT ) to evaluate the intrinsic coa gulation path way (factor VIII , IX , XI, and XII activity). In children , coagulation values should match agerelated values." Me asurement of bleeding times was not obtained.
When a detailed analys is of coagulation values was indicated, it included repeated measur ements of the CSC, PT , aPTT, bleeding time, von Wi llebr and ' s anti gen and activity, collage n-bind ing activity, high-m olecular-weight kininogen, and the activity and co nce ntration of factors I, II, V, VII , VIII , IX , X, XI, XII, and XIII.
Ton sillectomy was performed with scissors, a rasp, and a snare. Patient s were fitted with a McI vor gag and administered gen eral anesthesia. Adults were prohibited from eating and drinking for at least 6 hours following surgery; the length of the prohibition for children was based on their age. During the prohibition , patient s rece ived fluids through an intravenous line. Post-tonsillectomy hemorr hage was treated exclusive ly with enoral sutures . A detailed preoperative analysis had been indicated for seven patients-preoperatively in five children who had repeated abnormal coagulation values prior to surgery and postoperatively in two patients (one child and one adult) who experienced serious post-tonsillectomy bleeding (table I) . Among the five children with preoperative abnormalities, coag ulation values retu rned to norma l in two, two had abnormal values as a result of the presence of lupus anticoag ulant, and one had a hereditary deficiency of factors IX and XII. None of these five exper ienced any postoperative bleeding . The two patients who underwent a detaile d postoperative analysis of coag ulation values because of postoperative hemorrhage included a 5-year-old boy and a 40-year-old man. Detailed analysis was indicated because in both, copious bilateral bleeding continued despite all local treatment measures and because the intensity of the bleeding appeared to increase. The 5-year-old boy exhibited blood-tinged sputum immediately after tonsillectomy; he subsequently developed diffuse and intensive bilateral bleeding that required surgical treatment 2 days later (his faucial pillars were sutured together). Although his coagulation values had been normal prior to surgery, detailed laboratory tests revealed that he had a mild factor IX deficiency (activity : 41%). The boy's history was positive; 2 years earlier, he had experienced postadenoidectomy hemorrhage , a fact that his parents had not disclosed until after he experienced his post-tonsillectomy hemorrhage. His postsuture course was uneventful, and purified coagulation 3 2 factors were not administered. The 40-year-old man had a negative history, but he experienced copious bilateral bleeding that required two surgical proced ures under general anesthesia within the first 2 hours following his tonsillectomy. The bleed continued even after the faucial pillars had been sutured together . The sutures were removed, the wounds were covered with gauze packi ng, and the pillars were sutured together again . A detailed analysis of his coagulatio n values revealed that he had a factor XIII deficie ncy (activity : 56%) . Despite the fact that he received purified factor XIII, 7 days later he again experienced copious bleeding that required two additional surgical procedures to control. During the second procedure, a packing was sutured over the wounds and removed 2 days later.
Another patient, a 28-year-old man, had been diagnosed with a factor VII deficiency (activity: 20%) during childhood , but he did not undergo detailed analysis or experience any post-tonsillectomy bleeding.
Discussion
Despite our best efforts to avoid it, bleeding remains the most significant complication of tonsillectomy and adenotonsillectomy. The intensity of bleeding sometimes warrants surgical treatment under general anest hesia andl or the administration of blood transf usions . Among the various risk factors for bleeding that have been sugges ted (e.g., gender, age, indica tion for surgery, surgical technique, and hemostasis technique), congenital or acquired "CompHealth really helped me find the dream job I've been looking for." -Dr. Genise Fraiman , Internal Medicine C all us tod ay at 800.365.8900 or 800.328.3666
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WEST VIRGINIA-OUTSTANDING OPPORTUNITY. A large hospital seeks a qualified ENT to share call with two other physicians in town . Be set up in your own practice with a large patient/referral baseguaranteeing your success. Work with some of the finest people and best equipment in the field. Live and play in a great area with a low cost of living , upscale communities and a fantastic education system. History. It has been written that a detailed history is the most sensitive tool for predicting post-tonsillectomy hemorrh age.? We do not agree, although we cert ainl y believe that takin g a history is mandatory. Histories can be inaccurate because of language problems, intentional concealment of information, a desire for surger y, a lack of intell igence , and a failure to recall previous bleeding epi sode s. Moreover, in the pediatric patient, the reli ability of the history has other limitations-particul arly that most children have not been expo sed to a hemo static challenge in the past.'? The 5-year-old boy in whom detail ed laborato ry testing was indicated had a positive (albeit undi sclosed) history of postadenoidectomy bleeding, but his most recent epi sode was clearly rel ated to the challeng e by surgery itself. The 40-year-old man had a neg ative history , but this finding was not truly relevant bec ause he had not previously undergone any surgical procedure. Thi s is not an unusual circumstance . In a series of 52 adenotonsillectomy patient s, Bolger et al found that 40 (76 .9%) were undergoing surgery for the first time ." Neither doe s a negative history exclude the possibility that the patient has an acquired or congenital coagulation abnormality. In the series by Bolger et ai, 49 of the 52 patients (94.2 %) had a negative family history, but 6 patients (11.5 %) were later found to have had a hemo stati c defect. I I Moreover, 2 of the patient s in that series had den ied taking aspirin until after they had experienced postsurgic al hemorrhage. Simi -1ar findings have been reported by others.v" Burk et al reported a negative history in two patients, one of whom was known to have von Willebrand ' s disease and one who had a documented facto r VIII de ficiency." De Diego et al describ ed two children with an unrem arkable history and normal coa gulation values who nevertheless expe rienced massive post-tonsillectomy hemorrhage. 14 In both cases, a diagnosis of von Willebrand ' s disease was made after detailed laboratory testing .
Even a positi ve history appears to have a low predictive value . In a pro spective study of96 tonsill ectomy patients, Clo se et al found that 6 (6.3%) indicated a positive history on a standardized que stionnaire." However, none of the 6 experienc ed post-tonsillectomy hemorrhage , including a 24-y ear-old wom an whose coagulation values were consi stent with a variant of von Willebrand ' s disease. On the other hand , 6 patients who did expe rienc e various degrees of bleeding all had a neg ative history . 15 In a study of 339 ton sillectomies, Howells et al repo rted that 10 patients (2.9%) who had a negative person al 34 history experienced secondary (>24 hr) post-tonsillectomy hemorrhage, although one of these pat ients did have a positive family history ." Even so, approximately 25% of all inherited hemostatic defe cts are the result of a spontaneous mutation or a variable expression of the disease, which cle arly limits the value of the family history." In a study by Kang et ai, six of seven patients (85 .7%) who were newly diagnosed with coagulopathy had no clinical or famil y history of bleeding. 17 Coagulation values. During our period of study, tonsillectomy was not performed in our clinic on any patient who se hemoglobin concentration was less than 10 gldl or who se platelet count was less than 150,000//-11. The presence of a funct ional platelet diso rder secondary to diabetes mellitu s, hyperten sion , hyperlipoproteinemia, orsmoking " would require an ev aluat ion of bleeding time, which we unfortunately did not perform.
Reliability of screening tests. Several studies have
been conducted to evaluate the predictive value of screening methods for post-tonsillectomy hemorrhage. Findings vary (table 2). Deitmer suggested that bleeding time should be used as a screening tool , based on the assumption that most cas es of post-tonsillectomy hemorrhage are related to functional platelet disorders.19 His recommendation differs from that of Schwerdtfeger and Dennebaum, who recommend that bleeding time be mea sured only in patients who have a po sitive history." Barberet al showed that bleeding time was not sensitive in predicting posttonsillectomy hemorrhage among patients who had a negative history ." It should also be con sidered that clinical features of funct ional platelet disorders in children are often missed or misdiagnosed. Finally, regular aspirin intake by children is uncommon.
Lekas et al 12 and Gumprecht and Cichon" recommended evalu ation of bleeding time in patients with a positive history , whereas Barber et aPI and Lind " argued that it has no predictive value .
The most common hemostatic defe cts-von Willebrand's disease and platelet dysfunction-can usually be detected by mea suring aPTT and bleeding time ,":" although the sensitivity of these test s is limited. 9 , 15,24 Von Willebrand ' s disease is acknowledged to be the most common hereditary bleeding disorder. In affected patient s, post-tonsillectomy hemorrhage is caused by either a qualitati ve or quantitative deficiency of von Will ebrand' s factor, which is important for platelet aggregation and platelet adhesion to endothelial surfaces. The classic find ing in these patients is an increase in aPTT, an increase in bleeding time , and a decrease in the concentration s of von Willebrand ' s factor or factor VIII. Another values playa minor role in the detection of coagulation disorders in patients who have a negative history of bleeding. Determination of the aPTT measures the intrinsic pathway of coagulation, and it is useful in diagnosing hemophilias (e.g., deficiencies in factor VIII, IX, or XI). However, aPTT is not sensitive when factor levels exceed 10% of normal. 25 Lupus anticoagulant is a term used to describe a phenomenon in aPTT testing that occurs when a patient's polyclonal antibodies influence the phospholipid-dependent reaction. In most cases, an abnormally long aPTT is related to the presence oflupus anticoagulant. 26 Polyclonal antibodies were first reported in 1952 by Conley and Hartmann, who detected them in patients who had systemic lupus erythematosus." They can also occur in patients who have minor infections of the upper airway tract, autoimmune deficiencies, WerIhof's disease (idio-Volume 83, Number 1 pathic thrombocytopenic purpura), or malignant lymphomas and in those who take several medications.13.15.24 The presence of lupus anticoagu lant is not associated with bleeding. We identified lupus anticoagulant in two children who had an abnormal aPTT . Yet despite the benign character of these abnormal coagulation values, the parents of both children chose to refuse surgery. Two other children with lupus anticoagulant did undergo surgery, and neither experienced post-tonsillectomy hemorrhage.
According to the AAO-HNS, screening laboratory tests are indicated only for patients who have a significant history of coagulation disorders." This recommendation is supported by several studies that revealed that abnormal coagu lation values are not necessarily associated with bleeding. In a prospective study of 1,603 children, Burket al observed that 16of31 patients (51 .6%) who had abnormal coagulation values achieved normalization within 1 week ." This coincides with our finding that repeated laboratory tests should be performed before any more detailed and costly tests are indicated. Particularly in children, abnormal aPTT values can occur secondary to repeated infections of the upper airway and then normalize shortly thereafter, as happened in two of our pediatric patients. Because abnormal coagulation values persisted in two other children, a detailed analysis of coagulation values was indicated, and it revealed a mild deficiency of coagulation factors. It is remarkable that post-tonsillectomy hemorrhage did not occur in these patients. Of note is the fact that even a diagnosed coagulation-factor deficiency may not necessarily result in postoperative bleeding, as was the case in the previously mentioned 28-yearold man, who had a factor VII deficiency; his postoperative course was uneventful.
Zwack and Derkay reported that laboratory screening tests did not identify two cases of coagulation disordervon Willebrand's disease and Ehlers-Danlos syndrome." Moreover, they reported that post-tonsillectomy hemorrhage did occur in another patient who had been administered coagulation factors. They concluded that bleeding rates are lower when patients are selectively tested, indicating that routine laboratory tests have a low predictive value for post-tonsillectomy hemorrhage.
In the study by Howells et aI, 30 of 39 patients (76.9%) with abnormal coagulation values had only borderline elevations and did not undergo repeat studies ." In the 9 patients who did undergo repeat studies, the values of 3 returned to normal and those of 3 others remained prolonged (no post-tonsillectomy hemorrhage). The final 3 patients were found to have lupus anticoagulant, Hageman 's factor deficiency, and no disorder, respectively . Post-tonsillectomy hemorrhage occurred in only one of the 39 patients (2.6%).
In their study of 1,603 children, Burk et al found that 15 of 31 patients (48.4%) who had initial laboratory abnormalitie s continued to experience prolonged abnormalities." Von Willebrand's disease was diagnosed in one of these patients, who was the only patient among 37 who experienced post-tonsillectomy hemorrhage who had an abnormal screening result.
On the other hand, Myssiorek and Alvi recommended that coagulation values be screened routinely." In their report of 14 patients with abnormal PT or aPTT levels who were medically cleared preoperatively, 2 (14.3 %) who experienced post-tonsillectomy hemorrhage were later found to have had von Willebrand's disease .
Kang et al also supported the idea of routine laboratory screening." They studied 1,061 patients who had a normal CBC , PT, and platelet count and found that aPTT values and bleeding times were elevated in 27 patients (2.5%). In this group, 17 (63.0%) experienced a return to normal , 8 (29 .6%) had prolonged times, and 2 (7.4%) had borderline values ; post-tonsillectomy hemorrhage oc- 36 curred in 4, one, and one, respectively. Von Willebrand's disease was detected in 5 patients, 3 of whom had an additional functional platelet defect or factor V deficiency.
Unidentified coagulation disorder. Compared with screening tests, detailed laboratory tests are costly and should therefore to be ordered with great care.v" It is our strong impression that both of our patients who had a previously unidentified coagulation disorder experienced a characteristic type of post-tonsillectomy hemorrhage: bilateral bleeding of increasing intensity that required repeated local treatments under general anesthesia. Instead of bleeding from a solitary source, these two patients experienced bleeding from the entire surface of the wound .
The estimated incidence of two coagulation disorders-hemophilia B and factor XIII deficiency-is 1 in 50,000 and 1 in 1 million, respectively. 18 According to the literature, we would have been much more likely to have encountered hemophilia A (incidence: 1 in 10,000) . The true incidence of von Willebrand' s disease is difficult to estimate, but rates of 1 in 500 have been reported.v-" However, we did not diagnose any of these abnormalities in any of our patients. The origin of the factor XIII deficiency in our 40-year-old patient remains unclear because his history was insignificant. Congenital factor XIII deficiency is characterized by severe and life-threatening bleeding from the umbilical cord stump and persistent bleeding following injury or surgery during childhood . Unlike the case with hemophilia, joint bleeding is rare in congenital factor XIII deficiency. Acquired factor XIII deficiency is typically associated with liver disease, inflammatory diseases, systemic hematologic diseases, disseminated intravascular coagulation, and septicemia."
Because of the retrospective nature of our study , we were not able to ascertain the predictive value ofaPTT and PT because data were not available on patients with borderline or abnormal values who did not undergo surgery. Medicolegal considerations precluded us from operating on these patients.
Conclusions
Based on our finding s, we arrived at eight conclusions:
• Patients must complete a standardized questionnaire prior to any surgical procedure, for medicolegal reasons if for no other. However, the surgeon must keep in mind the many factors that can hinder interpretation of results , such as the patient's age, ability to complete questionnaires correctly, intelligence, and desire for surgery , as well as language problems and the intentional concealment of data.
• Normal coagulation values in screening laboratory tests do not exclude the possibility of a coagulation disorder.
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WARNINGS
• Mild hemophilia, von Willebrand ' s disease, and intake of oral anticoagulants are the most com mon causes of coagulopathi es in clin ically normal patients. Such patient s can occas ionally be identified by the rout ine measurement of PT, aPTT , and bleeding times, but these coagulopathies can also arise de novo durin g the postopera tive period .
• Abn ormal aPTT values are caused in most cases by antiphospholipid antibodies that have no influ enc e on coagulation in vivo.
• Variability in the clini cal history and coagulation values is a hallmark of patients with hemophilia.
• A detailed analy sis of coag ulation values is indic ated when copious bilateral bleedin g fails to adequately respond to surgical treatment and the intensity of the bleeding is not related to the surgical techniqu es, arterial hypertension , or the intake of anticoag ulants .
• The presence of coag ulation disorders in patients who have no sig nificant history and normal coag ulation values is extre mely rare. However , because post-tonsillectomy hemorrh age is not always related to local factors, surgeo ns should be prepared to treat coag ulation disorders when they are present.
